Nature Communications (Mar 2022)
Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells
Abstract
Clonal dynamics and selection have not been fully understood in patient-derived xenografts (PDX) of acute myeloid leukemia (AML). Here, the authors generate 160 AML-PDX models to track the clonal dynamics of primary and relapsed AML, and find selectively enriched subclones that are associated with resistance to therapy.